Search clinical trials for: CDK4/6 inhibitor, advanced solid tumor
Total 53799 results
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
Eli Lilly and CompanyCompletedMetastatic Castration-Resistant Prostate CancerFrance, United States, Spain
-
Henan Cancer HospitalRecruitingDigestive System TumorsChina
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
RenJi HospitalRecruiting
-
Eli Lilly and CompanyCompletedMetastatic Cancer | Advanced CancerChina
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingLiposarcoma, DedifferentiatedUnited States
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Yonsei UniversityActive, not recruiting
-
Novartis PharmaceuticalsCompletedTumors With CDK4/6 Pathway ActivationUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
G1 Therapeutics, Inc.TerminatedSmall Cell Lung CancerUnited States, Croatia, Belgium, Slovakia, Bosnia and Herzegovina, North Macedonia, Serbia, Slovenia
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
University of Texas Southwestern Medical CenterActive, not recruitingAbemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6Glioblastoma | Brain Tumor | GBM | Brain Tumor, RecurrentUnited States
-
Erasmus Medical CenterActive, not recruiting
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, H...
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingEndometrial CancerUnited States
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Taixing People's HospitalRecruiting
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Novartis PharmaceuticalsCompleted
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
University Hospital HeidelbergCompleted
-
American Society of Clinical OncologyPatient-Centered Outcomes Research InstituteNot yet recruitingMetastatic Breast Cancer
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Centre Francois BaclesseActive, not recruitingBreast Cancer | Metastatic Breast CancerFrance
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Safeway FoundationRecruiting
-
Saint Petersburg State Budgetary Healthcare Institution...Active, not recruitingThe Neoadjuvant TherapyRussian Federation
-
National Cancer Institute (NCI)Recruiting
-
Prelude TherapeuticsActive, not recruitingSarcoma | Breast Cancer | Glioblastoma | Malignant Mesothelioma | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung CancersUnited States, Singapore
-
Novartis PharmaceuticalsTerminated
-
Institut Paoli-CalmettesMerck KGaA, Darmstadt, Germany; National Cancer Institute, FranceNot yet recruiting
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHR+/HER2- Advanced and/or Metastatic Breast Cancer
-
University of VirginiaNovartis PharmaceuticalsUnknownGlioma | GlioblastomaUnited States
-
Sunnybrook Health Sciences CentreRecruitingMetastatic Breast CancerCanada
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Novartis PharmaceuticalsCompletedTeratomaSpain, Netherlands, United States, France
-
Shengjing HospitalActive, not recruiting
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly